News
-
-
-
PRESS RELEASE
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
Bluejay Diagnostics, Inc. announces baseline clinical characteristics from SYMON-II study, evaluating IL-6 as a biomarker for patients with sepsis and septic shock -
-
-
-
-
-
-
PRESS RELEASE
Solidion Technology (NASDAQ: STI) Sees no Basis to Increase Its Offer to Polar Power, Inc. (NASDAQ: POLA) in Response to Board Rejection of All-Cash Asset Acquisition Proposal
Solidion Technology, Inc. reaffirms disciplined acquisition strategy and commitment to maximizing shareholder value following Polar Power, Inc.'s rejection of all-cash asset acquisition proposal